Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru.

• Main Authors: Brett M Forshey (Author), Robert C Reiner (Author), Sandra Olkowski (Author), Amy C Morrison (Author), Angelica Espinoza (Author), Kanya C Long (Author), Stalin Vilcarromero (Author), Wilma Casanova (Author), Helen J Wearing (Author), Eric S Halsey (Author), Tadeusz J Kochel (Author), Thomas W Scott (Author), Steven T Stoddard (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2016-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BACKGROUND:Nearly half of the world's population is at risk for dengue, yet no licensed vaccine or anti-viral drug is currently available. Dengue is caused by any of four dengue virus serotypes (DENV-1 through DENV-4), and infection by a DENV serotype is assumed to provide life-long protection...